178 related articles for article (PubMed ID: 8449968)
1. Contributions of nuclear medicine to the therapy of malignant tumors.
Feinendegen LE
J Cancer Res Clin Oncol; 1993; 119(6):320-2. PubMed ID: 8449968
[TBL] [Abstract][Full Text] [Related]
2. Contributions of nuclear medicine to the therapy of malignant tumors.
Feinendegen LE
Strahlenther Onkol; 1991 Nov; 167(11):619-27. PubMed ID: 1962275
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
Aghevlian S; Boyle AJ; Reilly RM
Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic radionuclides: production and decay property considerations.
Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR
J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
[TBL] [Abstract][Full Text] [Related]
6. Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography.
Nichols TL; Kabalka GW; Miller LF; Khan MK; Smith GT
Med Phys; 2002 Oct; 29(10):2351-8. PubMed ID: 12408309
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy using alpha emitters.
Vaidyanathan G; Zalutsky MR
Phys Med Biol; 1996 Oct; 41(10):1915-31. PubMed ID: 8912371
[TBL] [Abstract][Full Text] [Related]
8. Radiobiologic implications of the microscopic distribution of energy from radionuclides.
Adelstein SJ; Kassis AI
Int J Rad Appl Instrum B; 1987; 14(3):165-9. PubMed ID: 3312115
[TBL] [Abstract][Full Text] [Related]
9. Targeted radiotherapy using Auger electron emitters.
O'Donoghue JA; Wheldon TE
Phys Med Biol; 1996 Oct; 41(10):1973-92. PubMed ID: 8912375
[TBL] [Abstract][Full Text] [Related]
10. Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions.
Cunningham SH; Mairs RJ; Wheldon TE; Welsh PC; Vaidyanathan G; Zalutsky MR
Br J Cancer; 1998 Jun; 77(12):2061-8. PubMed ID: 9649115
[TBL] [Abstract][Full Text] [Related]
11. Dosimetry of Auger-electron-emitting radionuclides: report no. 3 of AAPM Nuclear Medicine Task Group No. 6.
Humm JL; Howell RW; Rao DV
Med Phys; 1994 Dec; 21(12):1901-15. PubMed ID: 7700197
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric aspects of radiolabeled antibodies for tumor therapy.
Humm JL
J Nucl Med; 1986 Sep; 27(9):1490-7. PubMed ID: 3528417
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. The assessment and management of risks associated with exposures to short-range Auger- and beta-emitting radionuclides. State of the art and proposals for lines of research.
Paquet F; Barbey P; Bardiès M; Biau A; Blanchardon E; Chetioui A; Lebaron-Jacobs L; Pasquier JL
J Radiol Prot; 2013 Mar; 33(1):R1-16. PubMed ID: 23296029
[TBL] [Abstract][Full Text] [Related]
15. A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative.
Müller C; Zhernosekov K; Köster U; Johnston K; Dorrer H; Hohn A; van der Walt NT; Türler A; Schibli R
J Nucl Med; 2012 Dec; 53(12):1951-9. PubMed ID: 23139086
[TBL] [Abstract][Full Text] [Related]
16. Radionuclide therapy with iodine-125 and other auger-electron-emitting radionuclides: experimental models and clinical applications.
Bodei L; Kassis AI; Adelstein SJ; Mariani G
Cancer Biother Radiopharm; 2003 Dec; 18(6):861-77. PubMed ID: 14969599
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic radiopharmaceuticals.
Ercan MT; Caglar M
Curr Pharm Des; 2000 Jul; 6(11):1085-121. PubMed ID: 10903384
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy using antisense oligodeoxynucleotides labeled with Auger-emitting radionuclides.
Kairemo KJ; Tenhunen M; Jekunen AP
Cancer Gene Ther; 1998; 5(6):408-12. PubMed ID: 9917096
[TBL] [Abstract][Full Text] [Related]
19. A new calculational method to assess the therapeutic potential of Auger electron emission.
Humm JL; Charlton DE
Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):351-60. PubMed ID: 2753759
[TBL] [Abstract][Full Text] [Related]
20. Options to meet the future global demand of radionuclides for radionuclide therapy.
Das T; Pillai MR
Nucl Med Biol; 2013 Jan; 40(1):23-32. PubMed ID: 23116551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
